tiprankstipranks
Trending News
More News >
Cts Corp. (CTS)
NYSE:CTS
US Market
Advertisement

CTS (CTS) Earnings Dates, Call Summary & Reports

Compare
124 Followers

Earnings Data

Report Date
Oct 22, 2025
Before Open (Confirmed)
Period Ending
2025 (Q3)
Consensus EPS Forecast
0.61
Last Year’s EPS
0.63
Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings

Earnings Call Summary

Q2 2025
Earnings Call Date:Jul 24, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
The earnings call highlighted strong growth in diversified end markets, especially in the medical, aerospace, and defense sectors, alongside robust cash flow and shareholder returns. However, challenges remain in the transportation market due to China dynamics and diagnostic medical sales softness, compounded by ongoing trade tariff and geopolitical pressures.
Company Guidance
During the CTS Corporation's Second Quarter 2025 Earnings Call, the company provided guidance reflecting a continued focus on diversification and growth across various end markets. The company reported sales of $135 million, representing a 4% increase from the same quarter the previous year, with diversified end market sales up 13%, driven by organic growth and the SyQwest acquisition. Adjusted EBITDA improved by 250 basis points sequentially and 130 basis points year-over-year, while the adjusted gross margin was up 296 basis points year-over-year to 38.7%. Transportation sales saw a decline of 6% due to China's market dynamics, but positive developments were noted in medical, industrial, and aerospace and defense markets. The company maintained its full-year sales guidance in the range of $520 million to $550 million and adjusted diluted EPS between $2.20 and $2.35, despite potential headwinds from tariffs and geopolitical uncertainties. The book-to-bill ratio stood at 1 for the second quarter, and total booked business was approximately $1 billion. The company emphasized strong cash generation, with $28 million in operating cash flow for the quarter, and continued strategic focus on acquisitions and diversification.
Diversified End Market Growth
Sales to diversified end markets increased 13% year-over-year, with strong performance in the medical, aerospace, defense, and industrial sectors.
Medical Market Progress
Medical sales were up 8% year-over-year, with therapeutic product demand increasing approximately 60% year-over-year and new customer wins in ultrasound applications.
Aerospace and Defense Expansion
Aerospace and Defense sales increased by 34% year-over-year, driven by the SyQwest acquisition and a healthy backlog of orders.
Industrial Market Improvement
Industrial sales increased 6% year-over-year, with bookings up 22%, and new business awards for EV charging stations in Europe.
Strong Cash Flow and Shareholder Returns
Generated $28 million in operating cash flow in the second quarter, repurchased 412,000 shares for $17 million, and returned $26 million to shareholders through dividends and buybacks.

CTS (CTS) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

CTS Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Oct 22, 2025
2025 (Q3)
0.61 / -
0.63
Jul 24, 2025
2025 (Q2)
0.55 / 0.57
0.545.56% (+0.03)
Apr 30, 2025
2025 (Q1)
0.49 / 0.44
0.47-6.38% (-0.03)
Feb 04, 2025
2024 (Q4)
0.54 / 0.53
0.4712.77% (+0.06)
Oct 29, 2024
2024 (Q3)
0.54 / 0.63
0.5416.67% (+0.09)
Jul 30, 2024
2024 (Q2)
0.53 / 0.54
0.59-8.47% (-0.05)
May 01, 2024
2024 (Q1)
0.41 / 0.47
0.61-22.95% (-0.14)
Feb 06, 2024
2023 (Q4)
0.46 / 0.47
0.56-16.07% (-0.09)
Oct 26, 2023
2023 (Q3)
0.56 / 0.54
0.62-12.90% (-0.08)
Jul 25, 2023
2023 (Q2)
0.55 / 0.59
0.62-4.84% (-0.03)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

CTS Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Jul 24, 2025
$40.44$42.00+3.86%
Apr 30, 2025
$39.85$38.04-4.54%
Feb 04, 2025
$49.18$46.98-4.47%
Oct 29, 2024
$48.41$49.60+2.46%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Cts Corp. (CTS) report earnings?
Cts Corp. (CTS) is schdueled to report earning on Oct 22, 2025, Before Open (Confirmed).
    What is Cts Corp. (CTS) earnings time?
    Cts Corp. (CTS) earnings time is at Oct 22, 2025, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is CTS EPS forecast?
          CTS EPS forecast for the fiscal quarter 2025 (Q3) is 0.61.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis